The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced.
|TurboGFP||Bgl II||Sac I||EcoR I||Sal I||Kpn I||Apa I*||BamH I||Stops||attL2 site|
|Xho I||Hind III||Pst I*||Sac II|
* – not unique site.
Gateway® TurboGFP-C entry clone is a vector containing green fluorescent protein TurboGFP gene variant with codon usage optimized for high expression in mammalian cells (humanized) [Haas et al., 1996] (see reporter description). TurboGFP coding sequence is flanked by attL1 and attL2 sites allowing easy site-specific recombination. The Invitrogen Gateway® Technology provides a rapid and highly efficient way to transfer the TurboGFP gene into a number of Gateway® destination vectors for expression in different experimental systems. Multiple cloning site (MCS) located at the 3'-end of TurboGFP gene allows to generate fusions to the TurboGFP C-terminus for expression, localization and cellular dynamics studies.
To increase mRNA translation efficiency, Kozak consensus translation initiation site is generated upstream of the TurboGFP coding sequence [Kozak, 1987].
The vector backbone contains pUC origin of replication and kanamycin resistance gene (Kanr) for propagation and selection in
Generation of TurboGFP fusion proteins
A localization signal or a gene of interest can be cloned into MCS of the vector both before and after site-specific recombination with a destination vector. It will be expressed as a fusion to the TurboGFP C-terminus when inserted in the same reading frame as TurboGFP and no in-frame stop codons are present.
Alternatively, TurboGFP gene can be fused to the 3'-end of a gene of interest by LR recombination of the Gateway® TurboGFP-C with a destination vector containing this gene in a correct reading frame. In this case, the protein of interest will be expressed as a fusion to the TurboGFP N-terminus.
TurboGFP-tagged fusions retain fluorescent properties of the native protein allowing fusion localization in vivo.
Note: The plasmid DNA was isolated from dam+-methylated
LR site-specific recombination
Please refer to Invitrogen Gateway® Technology description for detailed instructions regarding LR site-specific recombination reaction. In general, to transfer TurboGFP gene or TurboGFP-fusion construct into the destination vector you will need:
- Purified plasmid DNA of Gateway® TurboGFP-C
- A destination vector of choice
- Invitrogen LR ClonaseTM II enzyme mix (Invitrogen Cat.# 11791-020)
- Proteinase K solution (supplied with the LR ClonaseTM II enzyme mix)
- TE-Buffer, pH 8.0 (10 mM Tris-HCl, pH 8.0, 1 mM EDTA)
- Appropriate chemically competent
- Appropriate selective plates.
Suitable host strains for propagation in
Location of features
attL1 site: 14-113
Kozak translation initiation site: 129-139
attL2 site: 908-1007
Kanamycin resistance gene: 2232-3026
pUC origin of replication: 3611-4254
TurboGFP-related materials (also referred to as "Products") are intended for research use only. The Products are covered by U.S. Pat. 7,678,893; European Pat. 1576157; and other Evrogen Patents and/or Patent applications pending. By use of these Products, you accept the terms and conditions of the applicable Limited Use Label License.
Invitrogen Gateway® Technology: please see Limited Use Label License No. 19: Gateway® Cloning Products.
Copyright 2002-2019 Evrogen. All rights reserved.
Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, Tel +7(495)988-4084, Fax +7(495)988-4085, e-mail:email@example.com